Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Apr 26, 2005

30339_dirs_2005-04-26_c062a025-0493-499d-8e6e-edd866c5263b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-04-22

Reporting Person: ALTEMUS LINDA R (VP & Chief Compliance Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-04-22 Common stocks A 11.21 $26.6100 Acquired 4271.5306 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common stocks 23411.3656 Direct
Common stocks 1382.5678 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.